Bacteriostatic water is sterile water plus 0.9% benzyl alcohol. Learn how that one preservative changes vial size, multi-dose use, and drug compatibility.
Bacteriostatic water is sterile water for injection containing 0.9% w/v benzyl alcohol as an antimicrobial preservative — roughly 9 mg per mL, or 83 mM. Sterile water contains nothing but water: no preservative, no buffer, no tonicity agent. That single additive is the entire difference, and it drives everything downstream. Benzyl alcohol allows a sealed vial to survive repeated septum penetration without microbial proliferation, which is why bacteriostatic vials are sold in 10 mL and 30 mL multi-dose formats while sterile water is typically packaged as 5 mL or 10 mL single-use ampoules. It also means bacteriostatic water is not an inert diluent from an analytical standpoint. Benzyl alcohol is UV-active, MS-ionizable, and present at concentrations that dwarf most research analytes.
Sterile Water for Injection USP is water that has been sterilized and packaged, with no added substances. The USP monograph sets pH at 5.0 to 7.0, bacterial endotoxins at not more than 0.25 EU/mL, and, for the purified water feedstock, conductivity of ≤1.3 µS/cm at 25 °C and total organic carbon of ≤500 ppb under USP <643>. It is sterilized terminally, most often by moist heat at 121 °C for 15 minutes or longer depending on load.
Bacteriostatic Water for Injection USP is the same water with benzyl alcohol added at 0.9% w/v. The monograph pH range widens slightly, generally cited as 4.5 to 7.0, because benzyl alcohol and its trace oxidation product benzaldehyde shift the profile marginally over shelf life. Benzyl alcohol itself: molecular weight 108.14 g/mol, boiling point 205 °C, density 1.044 g/cm³ at 25 °C, aqueous solubility around 40 g/L — so 9 g/L sits at roughly 22% of saturation, comfortably stable and not prone to phase separation at controlled room temperature.
Both are typically labeled with 24 to 36 months of unopened shelf life at USP controlled room temperature, 20–25 °C, with excursions permitted to 15–30 °C. Manufacturer in-use labeling on bacteriostatic multi-dose containers commonly specifies 28 days after first septum penetration, which is a preservative-efficacy claim under USP <51>, not a sterility guarantee.
This is the part most comparison pages skip entirely, and it matters more than the packaging difference.
At 0.9% w/v, benzyl alcohol is present at 83.2 mM. A research peptide reference material at 1 mg/mL with a molecular weight near 1,400 Da sits at roughly 0.7 mM. That is a ~120-fold molar excess of a small aromatic alcohol over the analyte of interest. Consequences for anyone running analytical confirmation on a diluted sample:
If your analytical method was validated against a sterile-water matrix and your samples are now in a bacteriostatic matrix, the method is no longer validated. That is a documentation problem, not just a chemistry problem.
The practical takeaway for a lab: the diluent is part of the sample matrix, and it belongs in the method file. Any certificate of analysis that reports purity from a chromatogram should identify what matrix the sample injection was made from.
Plainly: most single-timepoint analytical work does not need it, and buying it introduces an interferent for no benefit.
The cost argument is weaker than most buyers assume. A 30 mL bacteriostatic vial from a legitimate supplier typically runs $3 to $15; a 10 mL sterile water ampoule runs $1 to $4. On a per-mL basis bacteriostatic water is often cheaper — $0.10 to $0.50/mL versus $0.10 to $0.40/mL — so the decision is genuinely about matrix suitability, not budget. Spending an extra $6 to avoid re-validating an HPLC method is not a close call.
Treat water like any other reference material. Documentation standards do not relax because the product is simple. A defensible package includes lot-specific COA with benzyl alcohol assay by HPLC or GC, sterility and endotoxin results tied to that lot, a stated manufacture date and expiry, and storage conditions in writing. Supplier qualification for water is the same exercise as for any other input — see our approach in supplier and materials documentation and the scope statement under research use only.
Two questions separate real suppliers from repackagers: what is the measured benzyl alcohol assay on this lot, and what analytical method produced that number. A supplier that answers "0.9%, per label" has told you they did not test it.
Choose sterile water when the container is opened once, when detection happens below 230 nm, when mass spectrometry quantitation is involved, or when the analytical protocol was validated in a preservative-free matrix. Choose bacteriostatic water when a sealed container will be sampled repeatedly across days or weeks and microbial ingress at the septum is the controlling risk — and when the method has been characterized with benzyl alcohol present.
Neither product is a substitute for the other. They are two different matrices that happen to look the same in the vial. Documentation is what tells them apart after the label comes off, which is why lot traceability on something as ordinary as water is worth the two minutes it takes to verify. Full material documentation and lot records are available through contact, and the broader analytical reference set lives in the library.
Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.
Purity, identity and lot number, documented for the exact vial you receive.